基于功能性胃肠病的量表疗效评价研究进展

肖梦丽; 赵迎盼; 应佳珂; 陆芳

doi:10.3969/j.issn.1671-038X.2021.02.16

基于功能性胃肠病的量表疗效评价研究进展

- 1 中国中医科学院西苑医院临床药理所(北京, 100091);
- 2 中国中医科学院西苑医院脾胃病科
基金项目:
面向“一带一路”国家的中医药国际合作示范研究(No:2017YFC1703703)

详细信息

通讯作者: 陆芳,E-mail:deerfang@126.com

中图分类号: R573

收稿日期: 2020-11-28

Research progress of efficacy evaluation of scale based on functional gastrointestinal disorder

More Information

Corresponding author: LU Fang, E-mail: deerfang@126.com

Received Date: 28 November 2020

摘要

- 量表 /
- 功能性胃肠病 /
- 疗效
Abstract: As a kind of scale that can directly reflect the symptoms and problems that patients are most concerned about, it is a supplement to the outcome index of clinical efficacy evaluation. Based on the current development of functional gastrointestinal disorder scale at home and abroad, a comprehensive review of the current application in indigestion, reflux hypersensitivity, irritable bowel syndrome, constipation and so on scale, summarizes the basic situation of various scale and its application scope, summarizes current problems of scale, and analyzes the difficulties faced by the diseases of the functional gastrointestinal disorder scale in China and the existing gap, scale development trend was forecasted.
- scale /
- functional gastrointestinal disorder /
- efficacy evaluation

HTML全文

参考文献(37)

[1]	方秀才,译.罗马Ⅳ:功能性胃肠病(第2卷)[M].北京:科学出版社,2016:969-1130.
[2]	U.S.Department of Health and Human Services Food and Drug Administration.Guidance for Industry Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment[R/OL].(2012-05)[2020-10].http://www.fda.gov/downloads/Drugs/Guidances/UCM20529.
[3]	Veldhuyzen van Zanten SJ,Chiba N,Armstrong D,et al.Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials[J].Aliment Pharmacol Ther,2006,23(4):521-529.
[4]	Orive M,Antón-Ladislao A,González N,et al.New psychometric data from the Spanish versions of the Glasgow Dyspepsia Severity Score and the Dyspepsia-Related Health Scale measures[J].Rev Esp Enferm Dig,2018,110(1):10-18.
[5]	Leidy NK,Farup C,Rentz AM,et al.Patient-based assessment in dyspepsia:development and validation of Dyspepsia Symptom Severity Index(DSSI)[J].Dig Dis Sci,2000,45(6):1172-1179.
[6]	Sander GB,Mazzoleni LE,Francesconi CF,et al.Development and validation of a cross-cultural questionnaire to evaluate nonulcer dyspepsia:the Porto Alegre Dyspeptic Symptoms Questionnaire(PADYQ)[J].Dig Dis Sci,2004,49(11-12):1822-1829.
[7]	Mahadeva S,Chan WK,Mohazmi M,et al.Validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population[J].J Gastroenterol Hepatol,2011,26(11):1669-1676.
[8]	Fraser A,Delaney BC,Ford AC,et al.The Short-Form Leeds Dyspepsia Questionnaire validation study[J].Aliment Pharmacol Ther,2007,25(4):477-486.
[9]	Carbone F,Vandenberghe A,Holvoet L,et al.Validation of the Leuven Postprandial Distress Scale,a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome[J].Aliment Pharmacol Ther,2016,44(9):989-1001.
[10]	Hu WH,Lam KF,Wong YH,et al.The Hong Kong index of dyspepsia:a validated symptom severity questionnaire for patients with dyspepsia[J].J Gastroenterol Hepatol,2002,17(5):545-551.
[11]	Wen YD,Lu F,Zhao YP,et al.Epigastric pain syndrome:What can traditional Chinese medicine do?A randomized controlled trial of Biling Weitong Granules[J].World J Gastroenterol,2020,26(28):4170-4181.
[12]	Rabeneck L,Cook KF,Wristers K,et al.SODA(severity of dyspepsia assessment):a new effective outcome measure for dyspepsia-related health[J].J Clin Epidemiol,2001,54(8):755-765.
[13]	吴宇航.功能性消化不良生存质量量表(FDDQL)中文版再考核及其临床应用评价[D].广州:广州中医药大学,2011.
[14]	Tian XP,Li Y,Liang FR,et al.Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China[J].World J Gastroenterol,2009,15(25):3173-3177.
[15]	Mahadeva S,Wee HL,Goh KL,et al.Quality of life in South East Asian patients who consult for dyspepsia:validation of the short form Nepean Dyspepsia Index[J].Health Qual Life Outcomes,2009,7:45.
[16]	Nuevo J,Tafalla M,Zapardiel J.Validation of the Reflux Disease Questionnaire(RDQ)and Gastrointestinal Impact Scale(GIS)in patients with gastroesophageal reflux disease in the Spanish population[J].Gastroenterol Hepatol,2009,32(4):264-273.
[17]	宋玉磊,林征,林琳,等.中文版便秘患者症状自评量表的信度与效度研究[J].护理学杂志,2012,27(7):73-76.
[18]	Gholamrezaei A,Zolfaghari B,Farajzadegan Z,et al.Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients[J].Acta Med Iran,2011,49(6):390-395.
[19]	Azpiroz F,Guyonnet D,Donazzolo Y,et al.Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome:Validation of Symptom Frequency Questionnaire[J].J Clin Gastroenterol,2015,49(7):e64-e70.
[20]	梁炳君.中医脾胃系疾病PRO量表之肠易激综合征量表的研制与考核[D].广州:广州中医药大学,2010.
[21]	Slappendel R,Simpson K,Dubois D,et al.Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain[J].Eur J Pain,2006,10(3):209-217.
[22]	蒲秋霞,李红伟,宏亚丽.国外布里斯托大便分类法的应用现状及其启示[J].护理研究,2019,33(9):1552-1555.
[23]	Wojtyniak K,Szajewska H,Dziechciarz P.Translation to Polish,cross-cultural adaptation,and validation of the Bristol Stool Form Scale among healthcare professionals and patients[J].Prz Gastroenterol,2018,13(1):35-39.
[24]	Downing GM,Kuziemsky C,Lesperance M,et al.Development and reliability testing of the Victoria Bowel Performance Scale(BPS)[J].J Pain Symptom Manage,2007,34(5):513-522.
[25]	Tsunoda A,Yamada K,Takano M,et al.The translation and validation of the Japanese version of the patient assessment of constipation quality of life scale[J].Surg Today,2016,46(4):414-421.
[26]	李晓.便秘患者报告结局量表的研制及心理测量学考评[D].广州:广州中医药大学,2014.
[27]	Souza GS,Sardá FA,Giuntini EB,et al.Translation and validation of the brazilian portuguese version of the gastrointestinal symptom rating scale(GSRS)questionnaire[J].Arq Gastroenterol,2016,53(3):146-151.
[28]	De la Loge C,Trudeau E,Marquis P,et al.Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders:the PAGI-QOL[J].Qual Life Res,2004,13(10):1751-1762.
[29]	Rentz AM,Kahrilas P,Stanghellini V,et al.Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index(PAGI-SYM)in patients with upper gastrointestinal disorders[J].Qual Life Res,2004,13(10):1737-1749.
[30]	Sandblom G,Videhult P,Karlson BM,et al.Validation of Gastrointestinal Quality of Life Index in Swedish for Assessing the Impact of Gallstones on Health-Related Quality of Life[J].Value in Health,2009,12(1):181-184.
[31]	Lien HH,Huang CC,Wang PC,et al.Validation assessment of the Chinese(Taiwan)version of the Gastrointestinal Quality of Life Index for patients with symptomatic gallstone disease[J].J Laparoendosc Adv Surg Tech A,2007,17(4):429-434.
[32]	Tofangchiha S,Razjouyan H,Nasseri-Moghaddam S.Quality Of Life in Reflux and Dyspepsia(QOLRAD)Questionnaire in Iranian Patients with GERD:A Validation Study[J].Middle East J Dig Dis,2010,2(2):84-90.
[33]	赵贞贞,林征.功能性胃肠病患者生活质量测量工具的研究进展[J].护理研究,2011,25(3):575-577.
[34]	Ruiz M,Villasante F,León F,et al.[Dyspepsia-related quality of life.Spanish adaptation and validation of the questionnaire Dyspepsia-Related Health Scale][J].Med Clin(Barc),2001,117(15):567-573.
[35]	唐旭东,王萍,刘保延,等.基于慢性胃肠疾病患者报告临床结局测量量表的编制及信度、效度分析[J].中医杂志,2009,50(1):27-29.
[36]	王维琼.中医脾胃系疾病PRO量表的研制和考核[D].广州:广州中医药大学,2007.
[37]	Ang D,Talley NJ,Simren M,et al.Review article:endpoints used in functional dyspepsia drug therapy trials[J].Aliment Pharmacol Ther,2011,33(6):634-649.